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Background: Few population-based studies provide epidemiological data on infective endocarditis (IE). Aim of the
study is to analyze incidence and outcomes of IE in the Veneto Region (North-Eastern Italy).
Methods: Residents with a first hospitalization for IE in 2000-2008 were extracted from discharge data and linked
to mortality records to estimate 365-days survival. Etiology was retrieved in subsets of this cohort by discharge
codes and by linkage to a microbiological database. Risk factors for mortality were assessed through logistic
regression.
Results: 1,863 subjects were hospitalized for IE, with a corresponding crude rate of 4.4 per 100,000 person-years,
increasing from 4.1 in 2000-2002 to 4.9 in 2006-2008 (p = 0.003). Median age was 68 years; 39% of subjects were
hospitalized in the three preceding months. 23% of patients underwent a cardiac valve procedure in the index
admission or in the following year. Inhospital mortality was 14% (19% including hospital transfers); 90-days and
365-days mortality rose through the study years. Mortality increased with age and the Charlson comorbidity index,
in subjects with previous hospitalizations for heart failure, and (in the subcohort with microbiological data) in IE
due to Staphylococci (40% of IE).
Conclusions: The study demonstrates an increasing incidence and mortality for IE over the last decade. Analyses
of electronic archives provide a region-wide picture of IE, overcoming referral biases affecting single clinic or
multicentric studies, and therefore represent a first fundamental step to detect critical issues related to IE.
Background
Over the last years epidemiological characteristics of
infective endocarditis (IE) have been changing in indus-
trialized countries as a result of advances in medical
practice: decreasing prevalence of rheumatic heart dis-
ease as a predisposing condition, increased longevity,
increasing number of patients who undergo invasive
procedures [1-5]. Therefore, the emerging population at
risk for IE consists of patients with health care-
associated infections (acquired during hospitalization or
following invasive procedures performed in other
health-care settings) [6-8], elderly patients with valvular
sclerosis, patients with valvular prostheses, and haemo-
dialysis patients [1,5,9]. Most studies have recently
shown a trend towards increasing incidence of Staphylo-
coccus aureus endocarditis [1,10,11].
Morbidity and mortality are still considerable [2,5,10]:
the incidence of IE ranges within 3-10 episodes/100,000
person-year [2]; the in-hospital mortality rate of patients
with IE varies from 9,6 to 26% [2]. Larger studies are
usually multicentric surveys [1] with selected patients
(e.g., only centers with cardiac surgery, with a high pro-
portion of transferred patients) and limited follow-up
(only in-hospital or short-term). On the other hand, few
high quality population-based studies reviewed in 2007
[9] were heterogeneous as regards population size and
demographic structure (male/female ratio ranging from
1.2/1 to 2.5/1, mean or median age ranging from 51 to
69 years), case and outcome definition (from inhospital
mortality to 1 year mortality, with overall mortality ran-
ging from 14% to 46% according to different * Correspondence: ugo.fedeli@ulssasolo.ven.it
1SER - Epidemiological Department, Veneto Region, Italy
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The objective of our study was to provide population-
based descriptive epidemiological data of IE in the
Veneto Region (North-Eastern Italy) through linkage of
electronic archives of hospital discharge records (HDR)
and mortality records.
Methods
The total population of the Veneto Region was
4,885,548 on January 1, 2009. In the Region there are
about 65 hospitals (including public and private insti-
tutes) with an overall number of about 16,000 hospital
beds for acute care; there are approximately 900,000 dis-
charges from Veneto hospitals each year. One primary
and up to five secondary discharge diagnoses, plus one
primary and up to five secondary procedures are regis-
tered in the regional archive of HDRs, which includes
all discharges from Veneto hospitals and all discharges
of Veneto residents hospitalized outside the region.
HDRs with a primary or secondary International Classi-
fication of Diseases, 9th Revision, Clinical Modification
-versions 1997 and 2002- diagnosis code of IE (421.x =
acute and sub-acute endocarditis; 98.84 = gonococcal
endocarditis; 112.81 = candidal endocarditis) were
extracted starting from 1 January 1999.
In order to identify a cohort of incident cases with ade-
quate follow-up and to prevent double counting of the
included subjects, the first hospitalization (day-case
excluded) for IE in the years 2000-2008 was selected;
patients already discharged in 1999 with a diagnosis of IE
were removed (prevalent cases). Demographic (age, gen-
der) and clinical information (Charlson comorbidity
computed from discharge diagnoses [12]) were extracted
from the selected HDR. For each subject, all hospitaliza-
tions in the year before the first admission for IE were
traced and diagnostic and intervention codes analyzed in
order to retrieve information on comorbidities and risk
factors (cancer, diabetes mellitus, chronic renal failure,
congestive heart failure, previous cardiac valve surgery).
Furthermore, all hospitalizations in the year following the
first admission for IE were selected in order to gain infor-
mation on hospital transfers (zero or one day difference
between discharge and subsequent admission for IE),
overall in-hospital mortality, re-admissions, and cardiac
valve surgeries. Finally, the cohort of hospitalized IE was
linked to the regional mortality registry of the years
2000-2008 to estimate survival of patients; data were cen-
sored after a follow-up of 365 days.
The microbiologic aetiology of IE is rarely reported in
HDR by means of diagnostic codes 38.x or 41.x. Addi-
tionally, six regional hospitals sent microbiological data
to a common database in the years 2004-2006; informa-
tion on isolates from blood cultures was extracted and
linked to HDR to identify the causative microorganisms
and their influence on outcomes in such small subset of
the cohort.
The study was carried out on data routinely collected
by health services and linkage was performed on anon-
ymized records without any possibility of identification
of individuals. The study was approved by the Institu-
tional Review Board of the Vicenza Hospital.
Continuous variables are presented as medians with
interquantile ranges; categorical variables are presented
as frequencies/percentages. The presence of time trends
across the time periods was assessed by means of the
Chi-square test for linear trend or a non parametric
trend test derived from the Wilcoxon rank-sum test, as
appropriate. The influence of predictive variables on
short term mortality (dependent variable = vital status
at 90 days) was evaluated by computing the Odds Ratio
(OR) with 95% Confidence Intervals (CI). Variables
resulting statistically signifi c a n ta tu n i v a r i a t ea n a l y s i s
were selected by two models of stepwise logistic regres-
sion, including or excluding the Charlson index (which
already takes into account diseases reported in the index
admission). Statistical analyses were performed using
commercially available software (Stata version 9.1; SAS
version 9.1).
Results
After excluding prevalent cases, 1,863 residents in the
Veneto Region were hospitalized for IE in the period
2000-2008. The number of incident IE increased from
562 in 2000-2002 to 700 in 2006-2008 (+25%), with a
corresponding crude rate rising from 4.1 to 4.9 per
100,000 person-years (+17%; p = 0.003). Table 1 shows
the distribution of demographic characteristics, risk fac-
tors and comorbidities in the selected population, and
significant changes through 2000-2008. The male to
female ratio was 1.7:1, and 60% of subjects were aged 65
and older with a significant increase across the study per-
iod. The median age (interquantile range) was 68 years
(57-77) in the whole cohort, increasing from 66 years
(54-74) in 2000-2002 to 70 years (58-78) in 2006-2008
(p < 0.001). Globally, the rate of IE in people aged 65 and
older was 20.3 per 100,000 person-years in male and 10.9
per 100,000 in female subjects. About two out five sub-
jects were hospitalized in the three months preceding the
index admission; in 12% a diagnostic code for congestive
heart failure was reported in the year before the onset of
IE. Information retrieved both from the index and from
prior hospitalizations showed that a relevant proportion
of the cohort was affected by diabetes mellitus (16%),
cancer (10%), and chronic renal failure (8%).
Table 2 shows the sparse microbiological data
retrieved from diagnostic codes of HDR in the whole
cohort (available in 502 subjects), and from blood
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biological archive (available in 106 subjects). Although
raw (ICD9-CM codes can be hardly translated into a
microbiological classification), limited, and related to
different subsets of the cohort, the two sources of infor-
mation are consistent in indicating that about 40% of IE
were due to Staphylococci (mainly S. aureus), followed
by Streptococci, Enterococci and Gram negatives.
Table 3 shows surgical treatment and outcomes of IE.
The median length of stay increased from 23 to 33 days
when including hospital transfers, with a rising trend
through the study period. If the analysis was restricted
to survivors, the median stay was 24 and 35 days
excluding or including hospital transfers, respectively.
Furthermore, a substantial proportion of subjects surviv-
ing the first hospitalization were re-admitted (transfers
excluded) with a diagnostic code of IE within 1 year.
23% of subjects underwent a cardiac valve procedure in
the index admission or in the following year; such per-
centage heavily decreased with age (< 55 yrs = 36%;
55-64 yrs = 32%, 65-74 yrs = 23%; ≥75 yrs = 10%; p for
trend <0.001). Among subjects submitted to cardiac
valve procedures, 37% were treated in the index admis-
sion, 24% following an hospital transfer, and 38% in a
subsequent readmission within 1 year. The inhospital
mortality was 14.3% when excluding hospital transfers,
Table 1 Demographic and clinical characteristics of hospitalized subjects with infective endocarditis in 2000-2002,
2003-2005, 2006-2008, and p value of the Chi square test for linear trend across the study periods
2000-2002 (n = 562) 2003-2005 (n = 601) 2006-2008 (n = 700) p for trend
Age ≥ 65 years 52.31% 63.56% 63.43% < 0.001
Females 39.15% 41.60% 33.00% 0.017
Chronic renal failure 7.30% 7.99% 8.86% 0.309
Cancer 8.90% 11.15% 10.00% 0.563
Diabetes mellitus 16.01% 17.80% 15.29% 0.673
Previous congestive heart failure 12.99% 12.31% 11.43% 0.396
Valve procedures, previous 12 months 6.76% 5.49% 6.29% 0.767
All hospitalizations, previous 3 months 39.15% 41.60% 35.57% 0.159
Charlson index > 0 47.51% 48.92% 47.86% 0.927
Table 2 Microbiological data retrieved from secondary diagnostic codes in discharge records (n = 502), and from
blood culture samples (six hospitals, 2004-2006: n = 106)
Hospital discharge records Isolates from blood
Microorganism (ICD9-CM) n (%) Microorganism n (%)
Staphylococci 210 (42%) Staphylococci 41 (39%)
S. aureus (38.11, 41.11) 87 S. aureus 31
Coagulase-negative Staphylococci (38.19, 41.19) 30 Coagulase-negative Staphylococci 7
Staphylococcus spp (38.1, 38.10, 41.1, 41.10) 93 Staphylococcus spp 3
Streptococci + Enterococci 213 (42%) Streptococci+Enterococci 43 (41%)
Streptococci, all (38.0, 41.0x not 41.04) 186 S. bovis 11
S. mitis 8
Other Streptococci 11
Enterococci, all (41.04) 27 Enterococcus faecalis 10
Enterococcus spp.3
Gram-negative bacteria (38.4x, 41.3-41.7) 50 (10%) Gram-negative bacteria 13 (12%)
Others (38.2, 38.3, 41.2, 41.8, 98.84, 112.81 29 (6%) Others 9 (8%)
List of ICD-9-CM codes adopted:
38.1 Staphylococcal septicemia; 38.10 Staphylococcal septicemia, unspecified; 38.11 Staphylococcus aureus septicaemia; 38.19 Other staphylococcal septicemia
Bacterial infection in conditions classified elsewhere and of unspecified site: 41.1 Staphylococcus; 41.10 Staphylococcus, unspecified; 41.11 Staphylococcus aureus;
41.19 Other Staphylococcus
38.0 Streptococcal septicemia
Bacterial infection in conditions classified elsewhere and of unspecified site: 41.0 Streptococcus; 41.04 Group D [Enterococcus]
38.4 Septicemia due to other gram-negative organisms
Bacterial infection in conditions classified elsewhere and of unspecified site: 41.3 K. pneumoniae; 41.4 E. coli; 41.5 H. influenzae; 41.6 P. mirabilis; 41.7
Pseudomonas
38.2 Pneumococcal septicaemia; 38.3 Septicemia due to anaerobes
Bacterial infection in conditions classified elsewhere and of unspecified site: 41.2 Pneumococcus; 41.8 Other specified bacterial infections
98.84 gonococcal endocarditis; 112.81 candidal endocarditis
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study years; it rose to 18.5% when transfers were
accounted for. The linkage with mortality data showed
that a substantial proportion of deaths happened
between 30 and 90 days from the admission for IE
(Figure 1); an increasing time trend in overall mortality
was observed at 90 and 365 days of follow-up (Table 3).
Figure 1 shows survival of subjects according to age:
the survival curves of younger patients flatten after 60-
90 days, while curves of older patients (especially those
aged over 74) continue to drop until the end of follow-
up probably due to several comorbidities.
The raise of incident cases observed among residents
in the Veneto Region and the increase in 90-day fatality
p r o d u c e dag r o w i n gm o r t a l i t yr a t ea s s o c i a t e dt oI E ,
from 0.7 to 1.1 per 100,000 person-years (+65%; p <
0.001).
Table 4 shows the association of demographic and
clinical variables already reported in Table 1 with
90 days mortality; the risk of death increased with age
and the Charlson comorbidity index, in subjects hospita-
lized in the previous three months (only at univariate
analysis), in those with a previous diagnosis of heart fail-
ure, and in patients with a mention of cancer and
chronic renal failure. In the subsets of the cohort with
information on microbiology, infections due to Staphy-
lococci (n = 210/502 according to HDR) or to S. aureus
(n = 31/106 according to blood isolates) were
Table 3 Hospitalization data and follow-up of subjects with infective endocarditis (IE) in 2000-2002, 2003-2005, 2006-
2008, and p value of the test for linear trend across the study periods
2000-2002 (n = 562) 2003-2005 (n = 601) 2006-2008 (n = 700) p for trend
















Valve surgery in the index admission or within 1 year 23.5% 23.8% 22.0% 0.512
Repeated admissions with IE within 1 year among survivors 25.1% 25.2% 24.3% 0.645
90 days mortality 16.2% 20.8% 22.9% 0.004
365 days mortality 24.6% 28.8% 31.5%* 0.013
*data limited to 2006-2007.
Figure 1 Survival curves of subjects with infective endocarditis according to age class.
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OR (95% CI) equal to 3.0 (1.8-5.0) and to 4.2 (1.5-11.4),
respectively.
Discussion
Our study demonstrates an increasing trend in inci-
dence and mortality for IE in the Veneto Region over
the last decade. The main limit of the study is the lack
of validation of IE tracked by ICD9-CM discharge
codes: such disease misclassification could have led to
the inclusion of false positive cases and the exclusion of
false negatives. Discharge diagnoses were chosen based
on a pilot investigation carried out in recent years in a
single Veneto hospital by chart review of discharges
with a broader extraction of diagnostic codes, including
as well as 421.x, 98.84, 112.81, also 93.2 (syphilitic endo-
carditis), 391.1 (acute rheumatic endocarditis), 424.9x
(endocarditis, valve unspecified), 966.61 (infection and
inflammatory reaction due to cardiac device implant
and graft). IE diagnoses were validated according to the
modified Duke criteria [13], demonstrating a positive
predictive value and a sensitivity for IE of the selection
applied in the present study equal to 91/123 = 81% and
91/98 = 93%, respectively (Pellizzer, personnel commu-
nication). To what extent such findings are applicable to
the entire region and study period remains uncertain,
but disease misclassification does not probably account
for such sharp time trends found in our study; more-
over, the incidence rate (4.4 per 100000 person-years) is
in the range reported in literature and in particular it’s
similar to incidences estimated by multicenter prospec-
tive surveys conducted in other regions of Northern
Italy [14,15]. Furthermore, since the period analyzed to
exclude prevalent cases increases over time (minimum =
365 days in 2000), possibly not all prevalent cases have
been deleted from early study years, leading to a small
underestimation of the real increase of IE incidence; this
effect was tested using a constant wash-out time of 365
days through the study period.
Our investigation is a large population-based survey
spanning over several years that through record-linkage
allows for a complete follow-up of IE cases as regards
multiple outcomes: surgical interventions, hospital re-
admissions, short-term and middle-term mortality.
Descriptive data on incidence, surgical treatment, case-
fatality obtained by the record-linkage system are within
the range reported in the international literature. It must
be remarked that in our analyses day 0 is the date of
admission; as a consequence, health care-associated cases
would have altered figures on length of stay and survival.
However survival curves (except for the oldest age group)
flatten after the first 60-90 days from admission; there-
f o r e9 0 - d a ym o r t a l i t ys e e m st ob eag o o de s t i m a t eo f
short term mortality associated to IE. Although recent
studies report similar mortality rates in patients diag-
nosed and treated in tertiary care hospitals and those
referred to tertiary centres from other hospitals [16,17],
our data show that some usual outcome measures, such
as simple in hospital mortality, could be inadequate since
they miss a relevant burden of deaths occurring after dis-
charge at home or in subsequent hospitalizations.
On the other hand, constraints in clinical data (risk
factors, comorbidities, diagnostic work-out and medical
therapy) and the almost complete lack of microbiologi-
cal data derivable from HDR limit our interpretation.
Although more accurate diagnostic techniques (such as
a higher use of transesophageal echocardiography) can
play a role in rising incidence rates [18,19], we cannot
exclude that population at risk itself is increasing, con-
sidering the increasing share of elderly subjects among
patients with IE.
According to literature, we confirm a high mortality
associated to IE, particularly in older ages and in sub-
jects with comorbidities [2,10,20-22]; a novel finding is
Table 4 Variables associated to 90-days mortality: odds ratio (OR) with 95% Confidence Interval (CI), at univariate
analysis, and at stepwise logistic regression including (Model 1) or excluding (Model2) the Charlson index
Univariate Model 1 Model 2
OR (CI) OR (CI) OR (CI)
Age (years) 1.03 (1.02-1.04) 1.03 (1.02-1.04) 1.03 (1.02-1.04)
Gender (females vs males) 0.89 (0.70-1.13)
Chronic renal failure 1.83 (1.24-2.68) 1.50 (1.02-2.20)
Cancer 1.76 (1.23-2.49) 1.69 (1.20-2.38)
Diabetes mellitus 1.12 (0.81-1.52)
Previous heart failure 2.24 (1.63-3.06) 1.85 (1.35-2.56) 1.80 (1.32-2.48)
Previous valve procedures 1.11 (0.67-1.77)
Previous hospitalizations (3 mth) 1.35 (1.07-1.71)
Charlson index 1 vs 0 2.19 (1.66-2.87) 2.00 (1.52-2.65)
Charlson index ≥2 vs 0 2.78 (2.09-3.70) 2.44 (1.82-3.26)
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tions for heart failure. However, the increasing trend in
mortality can only partially be explained by the growing
number of affected elderly patients. It must be enlighten
that some well identified predictors of poor prognosis
such as some echocardiographic findings (size of vegeta-
tions, presence of periannular complications, severity of
valve dysfunction at diagnosis) and the presence of for-
eign material [2,18,23-25] couldn’t be deduced from
HDR. Moreover, we couldn’t get differences in treat-
ment protocols over time and among different hospitals.
In particular, our survey lacks information on indica-
tions for surgery; we found that 23% of patients under-
went surgical treatment, with a probability sharply
decreasing with age. Recent multicentric studies
reported surgery in about half of cases [1,26]. However,
some studies included only centres with cardiac surgery
units, and the percentage of surgical therapy decreased
when restricting analysis to patients admitted directly to
study sites [1]; moreover they dealt with a younger
population (median age under 60). Among population-
based studies, the share of patients submitted to surgery
ranged from 12.8% to 40% [9,14,15], with the exception
of a survey in France where 49% of subjects were surgi-
cally treated [27]. Although there are still some areas of
debate and individualized factors must be considered,
it’s been advocated that early surgery could be worth
even in patients with high operative risk [27]; in general,
in all IE cases, early surgical consultation is recom-
mended [2,26].
The high proportion of patients with previous hospita-
lization may explain the consistent - although limited -
microbiological data, being S. aureus the leading micro-
organism isolated. We also found that infections caused
by Staphylococci are significantly associated to mortality,
a finding consistent with literature [1,3,4,11,14,28].
Whether an increasing number and severity of comor-
bidities in subjects developing IE or, as previously
hypothized [1,4,11], an increasing share of IE due to Sta-
phylococci, could have led to the observed raise in mor-
tality remains uncertain and deserves further
investigations on a clinical basis.
Conclusions
The study demonstrates an increasing incidence and
mortality for IE over the last decade. Some usual out-
come measures (in hospital mortality) miss a relevant
burden of deaths occurring after discharge. Analyses
through electronic archives allow to draw a region-wide
picture of IE, overcoming those referral biases that una-
voidably affect single clinic or multicentric studies, and
therefore represent a first fundamental step to detect
critical issues related to infective endocarditis.
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